Structural Heart Devices Market to Cross USD 36.16 billion in 2032, expanding at a CAGR of 10.2%: Emergen Research

PRESS RELEASE

Published July 6, 2023

The global structural heart devices market size was USD 13.69 Billion in 2022 and is expected to register a steady revenue CAGR of 10.2% during the forecast period, according to latest analysis by Emergen Research. Advancements in medical technology and development of novel structural cardiac devices are major factors driving market revenue growth. Structural heart devices are equipment used to diagnose structural heart and valve disease, which is a condition characterized by problems with heart’s tissues or valves. Manufacturers consistently spend resources on Research & Development (R&D) to enhance the aesthetics, usability, and functionality of these gadgets. In addition, release of next-generation devices with increased functionality, better clinical outcomes, and lower hazards and technological developments including Three Dimensional (3D) printing, computer-assisted imaging, and robotic surgery are other key factors driving revenue growth of the market.

Moreover, increasing preference for minimally invasive procedures is also expected to drive market revenue growth during the forecast period. Compared to standard surgeries, minimally invasive procedures have a number of benefits, including decreased scarring, quicker recovery times, and cheaper healthcare expenses. Structural heart devices reduce the need for open heart surgery by allowing interventional cardiologists to execute intricate treatments using small incisions or catheter-based techniques. As a result of this trend, use of structural cardiac devices is spreading throughout many healthcare settings toward minimally invasive therapies.

To learn about additional key drivers, trends, and challenges – Read our Sample Report right now @ https://www.emergenresearch.com/request-sample/2001

However, shortage of suitably qualified healthcare workers is a major factor, which could restrain market revenue growth. Lack of competent experts in the field of structural heart devices present a significant constraint as major players in the market require trained and experienced workers at their facilities.

Furthermore, the world’s ageing population has played a significant influence in propelling the industry. With the elderly becoming increasingly vulnerable to heart disease, the need for structural heart devices has steadily increased. Furthermore, rising patient and healthcare professional awareness of the availability of sophisticated treatment options for structural heart disorders has supported market expansion.

Despite its strong growth trajectory, the structural cardiac devices industry is confronted with a number of obstacles and constraints. One of the primary impediments is the expensive cost of these gadgets. Advanced technologies and new procedures are frequently expensive, making them inaccessible in developing countries or to patients with low financial resources. Furthermore, the difficult and time-consuming nature of bringing innovative products to market is exacerbated by the strict regulatory structure governing their approval and marketing.

Some major companies in the market report include:

Medtronic plc, Cryolife Inc., Edwards Lifesciences Corporation, Abbott Laboratories, ST. JUDE MEDICAL, Medical Technology Est, Comed BV, Koninklijke Philips N.V., and Abbott.

To learn more details about the Global Structural Heart Devices Market report, visit @ https://www.emergenresearch.com/industry-report/structural-heart-devices-market

Edwards Lifesciences Corporation: Edwards Lifesciences is a market leader in structural cardiac devices, with a diverse product portfolio that includes transcatheter heart valves, annuloplasty rings, and delivery systems. The organisation has a significant global presence and focuses on continual innovation to improve patient outcomes.

Medtronic plc: Medtronic is a well-known medical technology firm that provides a diverse range of structural heart devices. Transcatheter aortic valves, closure devices, and annuloplasty rings are among their products. To increase its market position, the organisation prioritises strategic cooperation and partnerships.

Abbott Laboratories: Abbott Laboratories is a diversified healthcare company with a strong presence in the structural heart devices market. The company’s portfolio includes devices for transcatheter mitral and aortic valve replacement, as well as occlusion devices for septal defects. Abbott focuses on expanding its product offerings through acquisitions and product development initiatives.

CryoLife, Inc.: CryoLife is a leading provider of medical devices and surgical adhesives used in cardiac and vascular surgeries. The company offers a range of products for structural heart procedures, including implantable heart valves and surgical patch materials. CryoLife aims to strengthen its market presence through product launches and geographic expansion.

Some Significant Report Highlights:

The delivery systems segment is expected to account for largest revenue share in the global structural heart devices market over the forecast period. This is due to increasing adoption of minimally invasive techniques. Compared to open-heart surgery, minimally invasive procedures include benefits such as shorter hospital stays, quicker recovery times, less scarring, and cheaper healthcare expenses. Interventional cardiologists can precisely deploy structural cardiac implants by navigating through intricate anatomical structures with the use of delivery systems. In addition, these systems have sophisticated features, including guide wires, sheaths, and delivery catheters, making accurate device positioning possible and improving the procedure’s overall success. The requirement for effective and dependable delivery methods increases along with the need for minimally invasive techniques.
The repair procedures segment is expected to register significantly fast revenue growth rate in the global structural heart devices market over the forecast period. This is due to the fact that structural heart devices include benefits including lower discomfort, less blood loss, fewer problems, and quicker recovery times, compared to standard open surgery. In addition, these devices are becoming increasingly popular in general surgery owing to these benefits.
The North America market accounted for largest revenue share in the global in the global structural heart devices market in 2022. This is due to increasing availability of sophisticated healthcare infrastructure and expertise. Highly qualified medical staff with experience in executing intricate structural heart surgeries can be found in this region. In addition, rising adoption of structural heart devices in the area is facilitated by accessibility of cutting-edge technologies, sophisticated imaging modalities, and specialized heart centers. Furthermore, R&D ecosystem in North America is strong, promoting creativity along with technological advancements in the domain of structural heart devices.

Request a discounted copy of report @ https://www.emergenresearch.com/request-discount/2001

Segmental Analysis:

Emergen Research has segmented the global structural heart devices market on the basis of products, procedure, and region:

Products Outlook (Revenue, USD Billion; 2019-2032)

Delivery systems
Heart valve devices
Others

Procedure Outlook (Revenue, USD Billion; 2019-2032)

Repair procedures
Replacement procedures
Others

Regional Outlook:

North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Buy this report at an exclusively discounted rate @ https://www.emergenresearch.com/select-license/2001

Thank you for reading our report. Customization of the report is available according to the requirements of clients. In case of further queries about the report, do get in touch with us. Our team will make sure your report is tailored according to your needs.

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized r esearch reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the

Latest Published Reports by Emergen Research:

airborne lidar market

https://www.emergenresearch.com/industry-report/airborne-lidar-market

hydralazine market

https://www.emergenresearch.com/industry-report/hydralazine-market

https://www.blogger.com/profile/05862419503289705110

construction sealants market

https://www.emergenresearch.com/industry-report/construction-sealants-market

ai-enabled medical imaging solutions market

https://www.emergenresearch.com/industry-report/ai-enabled-medical-imaging-solutions-market

gerd drugs and devices market

https://www.emergenresearch.com/industry-report/gerd-drugs-and-devices-market